feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Hansa Biopharma: Klaus Sindahl, Head of Investor Relations presenterar på Redeye Investor AW – Göteborg 20 oktober 2022
October 21 2022